Boston Advisors LLC boosted its position in Aetna Inc. (NYSE:AET) by 10.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,534 shares of the company’s stock after acquiring an additional 1,231 shares during the period. Boston Advisors LLC’s holdings in Aetna were worth $1,993,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Bruderman Asset Management LLC bought a new position in Aetna in the second quarter valued at about $106,000. Liberty Capital Management Inc. boosted its holdings in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after acquiring an additional 629 shares during the last quarter. Westside Investment Management Inc. boosted its holdings in Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after acquiring an additional 400 shares during the last quarter. Phocas Financial Corp. bought a new position in Aetna in the second quarter valued at about $182,000. Finally, Deschutes Portfolio Strategy LLC bought a new position in Aetna in the second quarter valued at about $200,000. Institutional investors and hedge funds own 89.45% of the company’s stock.
Shares of Aetna Inc. (NYSE AET) opened at 173.12 on Monday. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $184.98. The firm has a market cap of $57.49 billion, a price-to-earnings ratio of 38.43 and a beta of 0.53. The stock’s 50 day moving average price is $159.32 and its 200-day moving average price is $151.29.
Aetna (NYSE:AET) last announced its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. During the same quarter in the prior year, the company earned $2.21 EPS. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. On average, analysts forecast that Aetna Inc. will post $9.49 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. Aetna’s payout ratio is 43.67%.
Several research firms recently issued reports on AET. Zacks Investment Research cut Aetna from a “buy” rating to a “hold” rating in a report on Tuesday, October 24th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $175.00 price target (up previously from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Jefferies Group LLC reiterated a “hold” rating and issued a $163.00 price target (up previously from $157.00) on shares of Aetna in a report on Friday, August 4th. Deutsche Bank AG raised their price target on Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a report on Monday, August 7th. Finally, Royal Bank Of Canada raised their price target on Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a report on Friday, August 4th. Nine research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $163.67.
In related news, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the sale, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the sale, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/10/30/boston-advisors-llc-purchases-1231-shares-of-aetna-inc-aet.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.